Page last updated: 2024-11-07

spironolactone and Cardiac Cancer

spironolactone has been researched along with Cardiac Cancer in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, DA1
Medline, NM1

Other Studies

1 other study available for spironolactone and Cardiac Cancer

ArticleYear
Spironolactone (aldactone) bodies: concentric lamellar formations in the adrenal cortices of patients treated with spironolactone.
    American journal of clinical pathology, 1970, Volume: 54, Issue:1

    Topics: Adrenal Glands; Adult; Aged; Chronic Disease; Cytoplasmic Granules; Female; Heart Failure; Heart Neo

1970